LifePlus
LifePlus builds the LifeLeaf non-invasive smartwatch and AI-driven platform that continuously monitor blood glucose, blood pressure, heart rate, and other biomarkers, serving chronic disease patients, healthcare providers, and caregivers across 27 countries via D2C and channel partnerships.
- Company typePrivate
- Founded2014
- HeadquartersSan Jose, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What LifePlus does
LifePlus, Inc. is a Silicon Valley-based private health technology company founded in 2014 (with its flagship product emerging from stealth in 2018) that develops the LifeLeaf non-invasive wrist-worn medical device and integrated software platform for continuous, multi-biomarker health monitoring. The hardware uses multi-sensor optical technology to measure blood glucose, blood pressure, heart rate, respiration rate, blood oxygen saturation, and steps without needles or cuffs, with reported clinical-grade accuracy of 10% MARD against BGM reference and cuff-comparable blood pressure readings validated in IRB-controlled multi-site studies. Data streams to a HIPAA-compliant cloud platform where proprietary AI/ML algorithms — trained on 70,000+ paired data points from 500+ subjects — generate actionable health insights delivered through a mobile app (iOS and Android), a patient user portal, and a caregiver portal for healthcare providers.
The company monetizes through a hybrid model: one-time hardware sales of the LifeLeaf smartwatch combined with recurring monthly SaaS subscription fees for the platform, app, and caregiver portal, with a stated intent to also capture revenue via remote patient monitoring reimbursement programs. Go-to-market is omnichannel: direct-to-consumer via the LifePlus website and mobile app stores, paired with a rapidly expanding network of strategic distribution partnerships that now place LifeLeaf in 27 countries across the EU (13), MENA (4), and APAC (12). Primary customer segments are patients with chronic conditions such as Type 2 diabetes, hypertension, COPD, atrial fibrillation, and sleep apnea, along with their healthcare providers and care teams; secondary segments include homecare/consumer wellness users and academic/research institutions conducting clinical studies on the platform.
Operationally, LifePlus is venture-backed and privately held, led by co-founders Alodeep Sanyal, PhD (CEO, ex-Intel) and Ben Mbouombouo (COO, 30+ issued USPTO patents), with a Chief Scientific Officer (Nilanjan Banerjee), Chief Medical Officer (Indranil Sen-Gupta), and a Medical Advisory Board spanning endocrinology, cardiology, and interventional cardiology. The IP estate comprises 13+ granted US patents covering non-invasive glucose concentration determination, tissue state classification, and adaptive monitoring ecosystems, with additional applications pending. No revenue, funding rounds, or institutional investor names are disclosed in the available material.
LifePlus firmographics
Firmographics- Name
- LifePlus
- Legal name
- LifePlus, Inc.
- Website
- https://lifeplus.ai
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- LifePlus builds the LifeLeaf non-invasive smartwatch and AI-driven platform that continuously monitor blood glucose, blood pressure, heart rate, and other biomarkers, serving chronic disease patients, healthcare providers, and caregivers across 27 countries via D2C and channel partnerships.
- Ownership category
- akta.pro rank
LifePlus industry classification
Industry- Product category
- Wearable Health Monitoring Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers) (CRACAQAE)
- akta.pro secondary industries
- Blood Pressure Monitors (Smart Cuffs) (CRACAQAB), Smartwatches & Connected Wearables (CRAKADAC), Pulse Oximeters & Respiratory Monitors (Consumer) (CRACAQAF)
Keywords
Where LifePlus is headquartered
LocationHeadquarters
- HQ city
- San Jose
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
LifePlus business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure
Revenue model
- Hardware Sales (LifeLeaf Smartwatch): LifePlus sells the LifeLeaf smartwatch as a one-time hardware purchase. The device is a single piece of hardware with no ongoing consumables (no needles, sensors, or finger sticks required).
- SaaS Subscription Services: LifePlus provides subscription services including the web portal, mobile app, and SaaS services accessible using the smartwatch product. Recurring monthly subscription charges apply for paid account types. Fees are auto-charged to the payment method on file, monthly until cancelled. All fees in USD and non-refundable. Cancellation requires 30-day notice.
- Remote Patient Monitoring Reimbursement: LifeLeaf delivers seamless capture, retention and presentation of health data to ensure maximum reimbursement under healthcare reimbursement programs. The homecare segment is expected to dominate the non-invasive blood glucose monitoring market by end-user.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Subscription-based SaaS with recurring monthly fees for access to the LifeLeaf platform, app, and caregiver portal. |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
LifePlus product offering
Product offeringCore offering
LifePlus develops and sells the LifeLeaf smartwatch, a wrist-worn non-invasive wearable that continuously measures blood glucose, blood pressure, heart rate, respiration rate, blood oxygen saturation, and steps using optical biosensors. The device pairs with a HIPAA-compliant cloud platform, a mobile application (iOS/Android), a patient user portal, and a caregiver portal that delivers AI/ML-driven insights for chronic care and remote patient monitoring. The company sells the hardware as a one-time purchase and offers the platform as a recurring monthly SaaS subscription.
Product overview
LifePlus offers the LifeLeaf and GlucoNow continuous health monitoring wearable products, all powered by the LIFELEAF® non-invasive continuous vital signs monitoring system. The portfolio consists of the LifeLeaf wrist-worn wearable device as the core hardware product, paired with the LifeLeaf Mobile Application (iOS/Android), LifeLeaf User Portal for patients, and LifeLeaf Caregiver Portal for healthcare providers. All devices connect to a HIPAA-compliant cloud platform that applies AI/ML algorithms to health data. GlucoNow is a secondary brand variant operating on the same platform.
Differentiator
Problem solved
Functional benefit
Brands
- LifeLeaf: World's first non-invasive device and platform that measures key health markers including blood glucose and blood pressure. A wrist-worn wearable device with AI-driven real-time health insights for continuous monitoring of chronic care biomarkers.
- LIFELEAF
Products and services
- LifeLeaf Smartwatch World's first non-invasive wrist-worn medical device that continuously monitors blood glucose, blood pressure, heart rate, respiration rate, blood oxygen saturation, steps, and meals using optical sensors, without needles or cuffs. Sold as a one-time hardware purchase to consumers and to healthcare provider programs for chronic care and remote patient monitoring.
- LifeLeaf Mobile Application Companion mobile app for iOS and Android that displays health data, trends, AI-driven insights, and alerts from the LifeLeaf smartwatch. Provides step-by-step user guide, pairing instructions, and firmware updates for end users.
- LifeLeaf User Portal Web-based portal where individual patients can view long-term health trends and detailed health records from anywhere, accessible using their LifeLeaf account.
- LifeLeaf Caregiver Portal Web portal allowing healthcare care teams, family caregivers, and providers to view real-time patient health trends and engage in proactive care management for remote patient monitoring programs.
- LifeLeaf Cloud Platform HIPAA-compliant cloud storage and analytics platform that streams health data from the LifeLeaf wearable device and applies AI/ML algorithms to generate actionable health insights, with seamless integration for third-party data sources such as EHR, lifestyle, nutrition, and fitness applications.
- GlucoNow Continuous health monitoring wearable product powered by the LIFELEAF non-invasive continuous vital signs monitoring system, functioning as a secondary brand variant of LifeLeaf targeting glucose monitoring use cases.
Quantifiable outcome
- Glucose readings within 10% MARD against BGM reference
- +5 more outcomes
Companies that use LifePlus
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
LifePlus technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability7 records
Feature7 records
LifePlus partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Strategic Partners (Europe, Asia, Middle East)coreLifePlus announced rapid global commercial expansion through new strategic partnerships across Europe, Asia, and the Middle East in June 2025. These partnerships cover distribution and commercial presence across 27 countries including EU states (Germany, Netherlands, Spain, etc.), MENA (UAE, Saudi Arabia), and APAC (Japan, Australia, India, Singapore). The expansion follows growing demand for LifeLeaf as the world's first non-invasive continuous glucose monitoring wearable.
Scale indicators7 records
Recent moves7 records
Expansion highlights5 records
LifePlus competitors and assessment
Company assessmentDirect peers
- Dexcom: Dexcom is the dominant FDA-cleared continuous glucose monitor maker (G6, G7) serving people with diabetes. LifePlus competes in the same CGM use case with a non-invasive optical approach vs. Dexcom's subcutaneous sensor.
- Abbott (FreeStyle Libre): Abbott's FreeStyle Libre is the world's highest-volume CGM (Libre 2, Libre 3) and the standard for non-insulin and insulin-using diabetes patients. LifePlus targets the same use case with a needle-free smartwatch instead of an arm-worn sensor patch.
- Medtronic (Guardian Connect / Simplera): Medtronic offers Guardian and Simplera CGM systems integrated with its insulin pumps. Like LifePlus, it pursues continuous glucose monitoring for chronic disease management, though via invasive subcutaneous sensors rather than optical.
Broad incumbents
- Apple (Apple Watch): Apple Watch provides HR, SpO2, ECG, and irregular rhythm notifications via FDA-cleared features, and is the dominant consumer smartwatch form factor. LifePlus competes for wrist-based health monitoring real estate but specializes in CGM/BP rather than general-purpose smartwatch functionality.
- Fitbit (Google): Fitbit (now part of Google) offers multi-day smartwatches and trackers with HR, SpO2, ECG, sleep, and irregular rhythm features. It competes with LifePlus on the consumer wellness smartwatch use case but does not target non-invasive CGM or BP.
- Garmin: Garmin produces health-tracking smartwatches (Venu, fēnix, Forerunner) with HR, SpO2, sleep, and stress features plus long battery life. Comparable wrist-based health monitoring competitor without glucose/BP focus.
Emerging players
- Oura: Oura sells the Oura Ring for continuous sleep, HR, temperature, and readiness monitoring with a subscription model. Comparable to LifePlus's recurring SaaS + wearable bundle, though ring-form-factor and no glucose/BP capability.
- Withings: Withings offers connected health devices (BPM Core, Body Scan, ScanWatch) covering blood pressure, ECG, sleep, and SpO2. Comparable to LifePlus on multi-biomarker home monitoring with cloud platform, but does not offer non-invasive glucose.
- BioIntellisense: BioIntellisense offers the BioSticker and BioButton for continuous multi-parameter wearable monitoring and remote patient monitoring services. Comparable to LifePlus's RPM enterprise motion for healthcare providers.
- Empatica: Empatica makes the FDA-cleared EpiMonitor (Embrace) for seizure detection and continuous physiological monitoring. Comparable medical-grade wearable + AI platform targeting chronic neurological and physiological conditions, with overlapping clinical/regulatory positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
LifePlus social profiles
Digital presenceLifePlus financial estimates
Financial estimateRevenue estimate
Valuation estimate
LifePlus leadership team
Management profileNumber of profiles
Profiles12 records
LifePlus funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LifePlus M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LifePlus
What does LifePlus do?
LifePlus develops and sells the LifeLeaf smartwatch, a wrist-worn non-invasive wearable that continuously measures blood glucose, blood pressure, heart rate, respiration rate, blood oxygen saturation, and steps using optical biosensors. The device pairs with a HIPAA-compliant cloud platform, a mobile application (iOS/Android), a patient user portal, and a caregiver portal that delivers AI/ML-driven insights for chronic care and remote patient monitoring. The company sells the hardware as a one-time purchase and offers the platform as a recurring monthly SaaS subscription.
Is LifePlus a public or private company?
LifePlus is a private company. It is classified as venture growth investor backed and is currently operating.
When was LifePlus founded?
LifePlus was founded in 2014. It employs 11 to 50 people.
Where is LifePlus based?
LifePlus is headquartered in San Jose, United States, in the North America region.
How does LifePlus make money?
Three revenue lines are on record. Hardware Sales (LifeLeaf Smartwatch) is the primary driver. The others are saaS Subscription Services and remote Patient Monitoring Reimbursement.
Who are LifePlus's main competitors?
Direct peers on record are Dexcom, Abbott (FreeStyle Libre) and Medtronic (Guardian Connect / Simplera). Broad incumbents are Apple (Apple Watch), Fitbit (Google) and Garmin. Emerging players are Oura, Withings, BioIntellisense and Empatica.
Does LifePlus have an API?
No public API is recorded for LifePlus.
What industry is LifePlus in?
LifePlus's product category is Wearable Health Monitoring Devices. Its primary akta.pro industry code is CRACAQAE, Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers), with a secondary code of CRACAQAB, Blood Pressure Monitors (Smart Cuffs). Its NAICS code is 334510 and its SIC code is 3845.